Influencer Reacts to Criticism ‘Ozempic Is Cheating’ After GLP-1 Weight Loss
Wellness influencer Janelle Rohner has seen the internet’s criticism after revealing she micro-dosed GLP-1 to lose weight. “‘Ozempic is cheating.’ ‘Ozempic is the easy way out,’” Rohner wrote via Instagram on Tuesday, June 17. “Here is my experience: You still need to prioritize macros, especially protein and fiber you need to continue to fuel your […]
FDA’s removal of Ozempic, Wegovy from drug shortage list upheld
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the drugs, was lawful and that the agency acted correctly. U.S. District Court Judge Mark Pittman found that the Outsourcing Facilities Association (OFA), an organization […]
Oxytocin stimulates pancreatic hormones to improve insulin secretion
A new research paper was published in Aging (Aging-US) Volume 17, Issue 5, on May 1, 2025, titled “Oxytocin modulates insulin and GLP-1 secretion in pancreatic islets.”
Is Ozempic Better Than Weight Loss Surgery?
GLP-1 drugs are the hot new kid on the weight loss scene, and for good reason. They appear to help people shed pounds by suppressing appetites and managing caloric intake. However, a new real-world study presented at the American Society for Metabolic and Bariatric Surgery’s 2025 scientific meeting has revealed a significant gap between the hype surrounding […]
Zealand Pharma’s GLP-1/GLP-2 candidate linked to 11.6% weight loss after 28 weeks
Zealand Pharma is back with updated findings for its GLP-1/GLP-2 receptor dual agonist, finding mean body weight reductions rose to 11.6% for a higher dosing regimen after 28 weeks in a phase 1b trial.
Weight-loss surgery trumps popular Ozempic treatment in shocking new comparison
Weight-loss surgery was shown to be five times more effective than weekly injections of popular GLP-1 receptor agonists, including semaglutide (such as Ozempic) and tirzepatide (such as Mounjaro). The finding comes from a recent study presented this week at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting in Washington. Researchers […]
Compounders lose case over semaglutide shortage
A federal court once again ruled against a trade group for large compounding pharmacies that sought to put Novo Nordisk’s blockbuster obesity drug semaglutide back on the FDA’s shortage list so compounders could continue making …
STAT+: Zealand’s GLP-2 candidate shows early weight loss results
Zealand Pharma said Wednesday that its obesity candidate that uses a unique mechanism led to notable weight loss in an early trial. Over 28 weeks, patients taking dapiglutide, which targets receptors of the GLP-1 and GLP-2 hormone, lost on average 11.6% of their weight, while those on placebo lost 0.2%. The company suggested the results […]
Mark Cuban’s company teams with telehealth firm on obesity drugs
Mark Cuban’s Cost Plus Drug Co. and virtual care provider 9amHealth have partnered to offer obesity medications through a new program targeting self-insured employers. Under the partnership, 9amHealth will use low-cost oral obesity medications sourced from Cost Plus Drugs alongside branded GLP-1 drugs acquired through direct manufacturer deals, according to a June 17 news release […]
Incretin Therapy: Bane Or Boon To Weight Loss
At a time when both international and domestic celebrities like Oprah Winfrey, Elon Musk, Rebel Wilson, Tracey Morgan, filmmakers Hansal Mehta and Karan Johar, plus star actors NTR Junior and Priyanka Chopra Jonas are becoming a talking point for their rapidly visible weight-loss programmes, speculations are rife over how they are pursuing their kilo-shedding goals. […]